Tech Company Financing Transactions

Gelesis Funding Round

Gelesis, based in Boston, secured $16 million from OrbiMed, PureTech Ventures and Queensland Investment Corporation.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

500 Boylston St. 1600
Boston, MA 02459
USA

Phone

(617) 456-4712

Website

www.gelesis.com

Email Address

[email protected]

Overview

Gelesis is transforming obesity and diabetes treatments. Learn how our smart pill (Gelesis100) can safely treat obese and diabetic patients.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Yishai Zohar

        

Chief Marketing Officer

Harry Leider

        

Chief Operating Officer

David Pass

        

Chief Scientific Officer

Elaine Chiquette

        

Chief Scientific Officer

Alessandro Sannino

        

Executive Vice President

Hassan Heshmati

        

VP - Regulatory Affairs

Eyal Ron

        

Browse more venture capital transactions:

Prev: 1/3/2008: Chelsio Communications venture capital transaction
Next: 1/3/2008: Cerulean Pharma venture capital transaction

Share this article

About Our Venture Capital Transactions Database

We do our best to document all VC transactions involving tech companies. VC investment data records reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary